Viewing Study NCT05594394


Ignite Creation Date: 2025-12-25 @ 1:32 AM
Ignite Modification Date: 2025-12-28 @ 12:01 AM
Study NCT ID: NCT05594394
Status: COMPLETED
Last Update Posted: 2023-10-18
First Post: 2022-10-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Improving Charge Nurse Conflict Resolution Communication Using Artificial Intelligence
Sponsor: Methodist Health System
Organization:

Study Overview

Official Title: Improving Charge Nurse Conflict Resolution Communication Using Artificial Intelligence
Status: COMPLETED
Status Verified Date: 2023-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Nurses are being challenged to provide increasingly complex care with more inexperienced nurses due to higher rates of retirement and registered nurse (RN) turnover in general.

High-performing charge nurses with excellent interpersonal, conflict management, communication, and leadership competencies are vital to achieving optimal outcomes. Implementing a charge nurse leadership development program focused on improving communication competencies in conflict management situations can support a healthy work environment.
Detailed Description: Freedman (2019) asserts that "interpersonal conflict in nursing workplaces is a pervasive and complex phenomenon, with implications for patient safety and quality of care" (p.594). First-time leaders seldom receive adequate training for effective transition to leadership roles, with 60% reporting having no training (Gentry, Logan, \& Tonidandel, 2014). Furthermore, many novice leaders struggle with transitioning from peer to leader, specifically related to interpersonal and communication skills (Basogul, 2020; Radovich, et al., 2011).

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: